Chief Medical Officer Summit Speakers
Tyler Martin, MD
CMO & Director
Dr. Martin is the President, Chief Medical Officer at Dynavax Technologies Corporation and a member of our Board of Directors. Dr. Martin has nearly 20 years of drug development experience. Before joining Dynavax in 2009, Dr. Martin was President of Humabs LLC. Previously, Dr. Martin worked at Chiron as the Vice President, Development from 2004 until 2006 and the Director, Clinical Research from 1994 until 1997. In his 7 years at Chiron, Dr. Martin led the team responsible for the development of the novel vaccine adjuvant MF59, the first vaccine adjuvant licensed by regulatory agencies since alum, and approved as FLUAD influenza vaccine in Europe. He has also held senior development and research positions at Sangamo, Inc., Valentis, Inc. and SyStemix/GTI. Dr. Martin received a BS in Chemistry and an MD from the University of Nebraska. He completed his fellowship in pediatric infectious diseases and molecular microbiology at Washington University in St. Louis, Missouri.